Charcot-Marie-Tooth disease: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz No edit summary |
||
| Line 4: | Line 4: | ||
This condition has been divided into two subtypes, hereditary motor and sensory neuropathy ( HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. <ref>Adams et al., ''Principles of Neurology'', 6th ed, p1343</ref> | This condition has been divided into two subtypes, hereditary motor and sensory neuropathy ( HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. <ref>Adams et al., ''Principles of Neurology'', 6th ed, p1343</ref> | ||
The genetic | The genetic abnormalities is associated with the coding for [[peripheral nerve myelin protein 22]]; additional subtypes have been discovered. It is most an autosomal dominant trait. | ||
Latest revision as of 12:31, 12 June 2010
Charcot-Marie-Tooth disease (CMT) is part of a family of genetically-defined neurologic diseases characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life.
This condition has been divided into two subtypes, hereditary motor and sensory neuropathy ( HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. [1]
The genetic abnormalities is associated with the coding for peripheral nerve myelin protein 22; additional subtypes have been discovered. It is most an autosomal dominant trait.
- ↑ Adams et al., Principles of Neurology, 6th ed, p1343